188 related articles for article (PubMed ID: 25575812)
1. Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins.
Rizkallah R; Batsomboon P; Dudley GB; Hurt MM
Oncotarget; 2015 Jan; 6(3):1446-61. PubMed ID: 25575812
[TBL] [Abstract][Full Text] [Related]
2. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
[TBL] [Abstract][Full Text] [Related]
3. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
[TBL] [Abstract][Full Text] [Related]
4. CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.
Stauffer S; Zeng Y; Zhou J; Chen X; Chen Y; Dong J
Cell Signal; 2017 Nov; 39():74-83. PubMed ID: 28780319
[TBL] [Abstract][Full Text] [Related]
5. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
6. A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis.
Abe Y; Takeuchi T; Kagawa-Miki L; Ueda N; Shigemoto K; Yasukawa M; Kito K
J Mol Biol; 2007 Jul; 370(2):231-45. PubMed ID: 17512944
[TBL] [Abstract][Full Text] [Related]
7. Global mitotic phosphorylation of C2H2 zinc finger protein linker peptides.
Rizkallah R; Alexander KE; Hurt MM
Cell Cycle; 2011 Oct; 10(19):3327-36. PubMed ID: 21941085
[TBL] [Abstract][Full Text] [Related]
8. Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.
Kim DJ; Li Y; Reddy K; Lee MH; Kim MO; Cho YY; Lee SY; Kim JE; Bode AM; Dong Z
Cancer Res; 2012 Jun; 72(12):3060-8. PubMed ID: 22523035
[TBL] [Abstract][Full Text] [Related]
9. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
[TBL] [Abstract][Full Text] [Related]
10. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
[TBL] [Abstract][Full Text] [Related]
11. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
[TBL] [Abstract][Full Text] [Related]
12. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
[TBL] [Abstract][Full Text] [Related]
13. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
[TBL] [Abstract][Full Text] [Related]
14. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
[TBL] [Abstract][Full Text] [Related]
15. TOPK and PTEN participate in CHFR mediated mitotic checkpoint.
Shinde SR; Gangula NR; Kavela S; Pandey V; Maddika S
Cell Signal; 2013 Dec; 25(12):2511-7. PubMed ID: 24012691
[TBL] [Abstract][Full Text] [Related]
16. A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains.
Dovat S; Ronni T; Russell D; Ferrini R; Cobb BS; Smale ST
Genes Dev; 2002 Dec; 16(23):2985-90. PubMed ID: 12464629
[TBL] [Abstract][Full Text] [Related]
17. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
Diao X; Yang D; Chen Y; Liu W
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
[TBL] [Abstract][Full Text] [Related]
18. PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.
Zhu K; Cheng X; Wang S; Zhang H; Zhang Y; Wang X; Chen Y; Wu J
Front Endocrinol (Lausanne); 2021; 12():706909. PubMed ID: 35126305
[TBL] [Abstract][Full Text] [Related]
19. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
[TBL] [Abstract][Full Text] [Related]
20. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells.
Nandi A; Tidwell M; Karp J; Rapoport AP
Blood Cells Mol Dis; 2004; 32(1):240-5. PubMed ID: 14757441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
